Oxcarbazepine
Oxcarbazepine is a generic prescription medication used as an anti-epileptic agent to help control seizures by stabilizing electrical activity in the brain. It comes in extended-release oral tablets in strengths of 150 mg, 300 mg, and 600 mg, manufactured by Ajanta Pharma USA Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Oxcarbazepine is a generic prescription medication used as an anti-epileptic agent to help control seizures by stabilizing electrical activity in the brain. It comes in extended-release oral tablets in strengths of 150 mg, 300 mg, and 600 mg, manufactured by Ajanta Pharma USA Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Oxcarbazepine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Oxcarbazepine — ANDA 202810 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202810"
}
]
|
| identifier | ANDA202810 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"drug-safety",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Oxcarbazepine |
